An Excerpt of 2022 European Association for the Study of the Liver Clinical Practice Guidelines on the Management of Cystic Liver Diseases
10.3969/j.issn.1008-7125.2023.01.006
- Author:
Jie YUAN
1
;
Guohong HAN
1
Author Information
1. Department of Digestive and Interventional Vascular Surgery, Xi'an International Medical Center Hospital
- Publication Type:Journal Article
- Keywords:
Biliary Hamartomas;
Caroli Disease;
Caroli Syndrome;
Cystic Liver Diseases;
Mucinous Cystic Neoplasms of the Liver;
Polycystic Liver;
Simple Hepatic Cysts
- From:
Chinese Journal of Gastroenterology
2023;28(1):31-35
- CountryChina
- Language:Chinese
-
Abstract:
The advent of enhanced radiological imaging techniques has facilitated the diagnosis of cystic liver lesions. Concomitantly, the evidence base supporting the management of these diseases has matured over the last decades. As a result, comprehensive clinical guidance on the subject matter is warranted. This guideline covers the diagnosis and management of hepatic cysts, mucinous cystic neoplasms of the liver, polycystic liver disease, caroli disease, caroli syndrome, biliary hamartomas and peribiliary cysts. On the basis of in⁃depth review of the relevant literature, this guideline provides recommendations to navigate clinical dilemmas followed by supporting text. The recommendations are graded according to the Oxford Centre for Evidence⁃based Medicine system and categorized as "weak" or "strong". This guideline aims to provide the best available evidence to aid the clinical decision⁃making process in the diagnosis and treatment of patients with cystic liver diseases, and presents the readers with translations and summarizations of the above mentioned recommendations.
